EMVision Medical Devices Ltd (ASX:EMV)

Market Cap	171.03M
Revenue (ttm)	5.05M
Net Income (ttm)	-9.81M
Shares Out	85.52M
EPS (ttm)	-0.11
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	102,602
Average Volume	41,128
Open	2.010
Previous Close	2.010
Day's Range	1.975 - 2.050
52-Week Range	1.630 - 2.270
Beta	0.81
RSI	72.65
Earnings Date	Aug 28, 2025

About EMVision Medical Devices

EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. The company offers non-invasive brain scanners bedside device emu, an ultra-light weight first responder pre-hospital device. EMVision Medical Devices Ltd was incorporated in 2017 and is based in Macquarie Park, Australia.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2017
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: EMV

Financial Performance

In 2025, EMVision Medical Devices's revenue was 5.05 million, a decrease of -54.97% compared to the previous year's 11.22 million. Losses were -9.81 million, 259.2% more than in 2024.